ORPHA:90321
Cockayne syndrome type 1
Also known as: Cockayne syndrome type I
Publications
5,067
Trials
0
Interventional, condition-specific
Researchers
1,318
Distinct authors in sample
Gene link
ERCC8
Definitive
Readiness
4/6
Stages with a signal
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0019569
- OMIM:216400
- UMLS:C0751039
- NCIT:C135725
Additional Mondo synonyms (5)
Cockayne syndrome A · Cockayne syndrome caused by mutation in ERCC8 · Cockayne syndrome type a · Cockayne syndrome, type A · ERCC8 Cockayne syndrome
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
4/6 stages with a signal
No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.
- Gene identifiedPresent
Definitive — ERCC8
- LiteraturePresent
5,067 matched papers (2,401 in last 10 years) Source
- Phenotype characterisedPresent
141 HPO annotations (e.g. Basal ganglia calcification; Proteinuria; Cataract) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPartial
None under the specific name; 5 for broader category Cockayne syndrome
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (ERCC8).
GenCC classification: Definitive.
Phenotypes (Monarch / HPO)
141
Associated phenotypes · MONDO:0019569
- Basal ganglia calcification
- Proteinuria
- Cataract
- Scoliosis
- Increased blood urea nitrogen
Showing 5 of 141 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
5,067
5,067 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
5,067 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
2,401 in the last 10 years · low confidence
Phrase hits: 4,628 · MeSH hits: 0
Who's working on it?
1,318
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Laugel V5 papers · 2026
Laboratoire de génétique médicale, Faculté de médecine de Strasbourg, Strasbourg, France.
Papers in Europe PMC - 02Liu L5 papers · 2026
Department of Medical Genetic and Prenatal Diagnosis, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Papers in Europe PMC - 03Wang X5 papers · 2025
Zhejiang Key Laboratory of Organ Development and Regeneration, College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou 311121, China.
Papers in Europe PMC - 04Calmels N4 papers · 2026
Laboratoire de génétique médicale, Faculté de médecine de Strasbourg, Strasbourg, France.
Papers in Europe PMC - 05Huang Y4 papers · 2026
Department of Central Laboratory, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian, China.
Papers in Europe PMC - 06Obringer C4 papers · 2026
Laboratoire de génétique médicale, Faculté de médecine de Strasbourg, Strasbourg, France.
Papers in Europe PMC - 07
- 08D'Errico M3 papers · 2022
Department of Environment and Health, Istituto Superiore di Sanità, 00161 Rome, Italy.
Papers in Europe PMC - 09De Benedetti A3 papers · 2025
Department of Biochemistry and Molecular Biology, Louisiana State University Health Shreveport, Shreveport, LA, United States.
Papers in Europe PMC - 10Krutmann J3 papers · 2026
IUF-Leibniz Research Institute for Environmental Medicine, Auf'm Hennekamp 50, D-40225 Duesseldorf, Germany.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name. 1 observational study did — shown below because natural-history and cohort work can be an important step toward a trial. 5 trials are registered for Cockayne syndrome, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
low confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
5 interventional trials matched Cockayne syndrome, the broader category — listed below. Those studies are not counted in the condition-specific total.
Broader category: Cockayne syndrome
5
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT06938542·ENROLLING BY INVITATION·Palliative Care Needs of Children With Rare Diseases and Their Families
Conditions: Trisomy 13 Syndrome · Arthrogryposis Congenita Multiplex With Intestinal Atresia · Asparagine Synthetase Deficiency · CHARGE Syndrome·Matched via name phrase
Observational and natural-history studies
1 observational study matches this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
None of the matched observational studies is currently listed as recruiting.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 1 · after dedupe 1 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 1 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (1)
- isrctn·ISRCTN18994246·No longer recruiting·Cryotherapy versus salicylic acid for the treatment of verrucae
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Cockayne syndrome type 1 — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("Cockayne syndrome type 1" OR "Cockayne syndrome type I" OR "Cockayne syndrome A" OR "Cockayne syndrome caused by mutation in ERCC8" OR "Cockayne syndrome type a" OR "Cockayne syndrome, type A" OR "ERCC8 Cockayne syndrome") OR ("ERCC8" OR "ERCC8 syndrome" OR "ERCC8-related")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Cockayne syndrome type 1" OR "Cockayne syndrome type I" OR "Cockayne syndrome A" OR "Cockayne syndrome caused by mutation in ERCC8" OR "Cockayne syndrome type a" OR "Cockayne syndrome, type A" OR "ERCC8 Cockayne syndrome"
Study-type breakdown: 0 interventional · 1 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"Cockayne syndrome"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (5067) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-27T03:44:20.021Z
